1 |
Clayton, D. and Leslie, A. (1981). The bioavailability of erythromycin stearate versus enteric-coated ery-thromycin base when taken immediately before and after food, Journal of International Medical Re-search, 9, 470-477
DOI
|
2 |
FDA (2000). Guideline for Industry: Bioavailability and Bioequivalence Studies for Orally Adminis-tered Drug Products? General Considerations, Rockville. Maryland: Center for Drug Evaluation Research, Food and Drug Administration
|
3 |
Ki, F. Y. C., Liu, J. P., Wang, W. and Chow, S. C. (1995). The impact of outlying subjects on decision of bioequivalence, Journal of Biopharmaceutical Statistics, 5, 71-94
DOI
ScienceOn
|
4 |
Liu, J. P. and Weng, C. S. (1991). Detection of outlying data in bioavailability / bioequivalence studies, Statistics in Medicine, 10, 1375-1389
DOI
ScienceOn
|
5 |
Metzler, C. M. and Huang, D. C. (1983). Statistical methods for bioavailability and bioequivalence, Clini-cal Research Practices and Drug Regulatory Affairs, 1, 109-132
DOI
|
6 |
Ramsay, T. and Elkum, N. (2005). A comparison of four different methods for outlier detection in bioe-quivalence studies, Journal of Biopharmaceutical Statistics, 15, 43-52
DOI
ScienceOn
|
7 |
Rodda, B. E. (1986). Bioequivalence of Solid Oral Dosage Forms, A presentation to the U. S. Food and Drug Administration Hearing on Bioequivalence of Solid Oral Dosage Forms, September 29-October 1, Pharmaceutical Manufacturers Association, Section Ⅲ, 12-15
|
8 |
Wang, W. and Chow, S. C. (2003). Examining outlying subjects and outlying records in bioequivalence trials, Journal of Biopharmaceutical Statistics, 13, 43-56
DOI
ScienceOn
|
9 |
식품의약품안전청 (2008). 생물학적동등성시험기준(제2008-22호)
|
10 |
Bolton, S. (1991). Outliers-Examples and Opinions, Presented at Bioavailability / Bioequivalence: Phar-macokinetic and Statistical Considerations sponsored by Drug Information Association, Bethesda, Maryland
|
11 |
Chow, S. C. and Liu, J. P. (2009). Design and Analysis of Bioavailability and Bioequivalence Studies, 3rd Ed., Chapman & Hall/CRC, Florida
|
12 |
Chow, S. C. and Tse, S. K. (1990). Outlier detection in bioavailability / bioequivalence studies, Statistics in Medicine, 9, 549-558
DOI
ScienceOn
|